We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pioneering Magnetic Sensor Technology to Revolutionize 24/7 Heart Monitoring

By HospiMedica International staff writers
Posted on 15 Dec 2023

Tunnel Magnetoresistance (TMR) is a quantum mechanical effect observed at the nanoscale, where the electrical resistance of a tiny insulating barrier placed between two ferromagnetic layers changes dramatically depending on their magnetic alignment. More...

If the magnetic orientations of these layers align parallel to each other, it becomes easier for electrons to tunnel through the barrier, resulting in lower resistance. Conversely, if the orientations are antiparallel, the electrons face a higher energy barrier, leading to a significant increase in resistance. This fascinating technology is now being leveraged to detect minute magnetic signals emitted by the body’s organs, such as the heart and arm muscles.

Neuranics (Scotland, UK) is at the forefront of developing this innovative magnetic sensor technology, aimed at enhancing health, fitness, and metaverse applications. Leveraging the TMR effect, Neuranics’ patented technology is capable of sensing tiny magnetic signals produced by the body’s muscles, offering a significant improvement in tracking health and fitness metrics and in developing interfaces between humans and machines. The company's magnetocardiography (MCG) sensors, designed for a single point of contact with the body or through light clothing, are set to replace the conventional 3-lead electrocardiography (ECG) sensors currently used in sports fitness gadgets and medical monitoring devices. These MCG sensors provide more detailed and clear insights into heart function, including blood flow within the heart's main valves.

Neuranics is preparing to launch a magnetic sensor development kit that captures the heart’s magnetic activity and wirelessly transmits this data via Bluetooth for continuous, round-the-clock recording and analysis on various devices like smartphones, tablets, or laptops. This upcoming kit will include Neuranics' latest magnetic sensor capable of detecting subtle magnetic signals from the heart muscle, prototype electronics, a Bluetooth interface, laptop analysis software, and an Android app. This kit will enable developers to explore the potential of magnetic sensors, with the provided software and app offering extensive customization options.

“With our breakthrough technology sports, fitness and healthcare companies can develop new products based on the benefits of magnetic sensors,” said CEO Noel McKenna.

Related Links:
Neuranics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.